Literatuurlijst Diagnostiek bipolaire stoornis bij ouderen

• Adityanjee, A., Munshi, K.R., & Thampy, A. (2005). The syndrome of irreversible lithium-effectuated neurotoxicity (Review). Clinical Neuropharmacology, 28, 38-49.
• Bourne, C., Aydemir, Ö., Balanzá-Martínez, V., Bora, E., Brissos, S., Cavanagh, J.T.O., e.a. (2013). Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatrica Scandinavica, 128, 149-162.
• Chen, S.T., Altshuler, L.L., Melnyk, K.A., Erhart, S.M., Miller, E., & Mintz, J. (1999). Efficacy of lithium vs. valproate in the treatment of mania in the elderly: a retrospective study. Journal of Clinical Psychiatry, 60, 181-186.
• Cullen, M., Mitchell, P., Brodaty, H., Boyce, P., Parker, G., Hickie, I., e.a. (1991). Carbamazepine for treatment-resistant melancholia. Journal of Clinical Psychiatry, 52, 472-476.
• Da Silva, J., Goncalves-Pereira, M., Xavier, M., & Mukaetova-Ladinska, E.B. (2013). Affective disorders and risk of developing dementia: systematic review. British Journal of Psychiatry, 202, 177-186.
• Depp, C.A., & Jeste, D.V. (2004). Bipolar disorders in older adults: a critical review. Bipolar Disorders, 6, 343-367.
• Dols, A., Rhebergen, D., Beekman, A., Kupka, R., Sajatovic, M., & Stek, M.L. (2014). Psychiatric and medical comorbidities: results from a bipolar elderly cohort study. American Journal of Geriatric Psychiatry, 22, 1066-1074.
• Forester, B.P., Streeter, C.C., Berlow, Y.A., Tian, H., Wardrop, M., Finn, C.T., e.a. (2009). Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study. American Journal of Geriatric Psychiatry, 17, 13-23.
• Freeman, M.P., & Freeman, S.A. (2006). Lithium: clinical considerations in internal medicine [Review]. American Journal of Medicine, 19, 478-481.
• Gareri, P., Segura-García, C., Manfredi, V.G., Bruni, A., Ciambrone, P., Cerminara, G., e.a. (2014). Use of atypical antipsychotics in the elderly: a clinical review. Clinical Interventions in Aging, 9, 1363-1373.
• Geddes, J.R., Goodwin, G.M., Rendell, J., Azorin, J.M., Cipriani, A., Ostacher, M.J., e.a. (2010). Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE):  a randomised open-label trial. Lancet, 375, 385-395.
• Gerhard, T., Huybrechts, K., Olfson, M., Schneeweiss, S., Bobo, W.V., Doraiswamy, P.M., e.a. (2014). Comparative mortality risks of antipsychotic medications in community-dwelling older adults. British Journal of  Psychiatry, 205, 44-51.
• Goldberg, J.F., Sacks, M.H., & Kocsis, J.H. (2000). Low-dose lithium augmentation of divalproex in geriatric mania. Journal of Clinical Psychiatry, 61, 304.
• Goossens, P.J.J., Knoppert-van der Klein, E.A.M., Kroon, H., & Achterberg, T. van (2007). Self-reported care needs of outpatients with a bipolar disorder in the Netherlands. Journal of Psychiatric and Mental Health Nursing, 14, 527-621.
• Gupta, S., Chohan, M., & Madhusoodanan, S. (2004). Treatment of acute mania with aripiprazole in an older adult with noted improvement in coexisting Parkinson’s Disease. Primary Care Companion to the Journal of Clinical Psychiatry, 6, 50-51.
• Himmelhoch, J., Neil, J.R., May, S.J., Fuchs, C.Z., & Licata, S.M. (1980).  Age, dementia, dyskinesias, and lithium response. American Journal of Psychiatry, 137, 941-945.
• Hirschfeld, R.M., Calabrese, J.R., Weissman, M.M., Reed, M., Davies, M.A., Frye, M.A., e.a. (2003). Screening for bipolar disorder in the community. Journal of Clinical Psychiatry, 64, 53-59.
• Jackson, J.W., Weele, T.J. van der, Viswanathan, A., Blacker, D., & Schneeweiss, S. (2014). The explanatory role of stroke as a mediator of the mortality risk difference between older adults who initiate first- versus second-generation antipsychotic drugs. American Journal of epidemiology, 180, 847-852.
• Jansen, P.A., Bekker, F.M., Nieuwkerk, J.F. van, Nolen, W.A., & Schols, D. (1989). Blijvende neurologische schade bij therapeutische concentraties van lithium in het plasma. Nederlands tijdschrift voor Geneeskunde, 133, 181.
• Kando, J.C., Tohen, M., Castillo, J., & Zarate, C.A. Jr. (1996). The use of valproate in an elderly population with affective symptoms. Journal of Clinical  Psychiatry, 57, 238-240.
• Kessing, L.V. (2004). Gender differences in the phenomenology of bipolar disorder. Bipolar Disorders, 6, 421-425.
• Kessing, L.V., Sondergard, L., Forman, J.L., & Andersen, P.K. (2008). Lithium treatment and risk of dementia. Archives of General Psychiatry, 65, 13311335.
• Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., & Walters, E.E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593-602.
• Konz, H.W., Meesters, P.D., Paans, N.P., Grootheest, D.S. van, Comijs, H.C., Stek, M.L., & Dols, A. (2014). Screening for metabolic syndrome in older patients with severe mental illness. American Journal of Geriatric  Psychiatry, 22, 1116-1120.
• Lala, S.V., & Sajatovic, M. (2012). Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. Journal of  Geriatric Psychiatry and Neurology, 25, 20-25.
• Lammeren, A. van, Dols, A., Gerven, H. van, Kupka, R.W., & Stek, M.L. (2011). Manie op latere leeftijd: bipolaire stoornis als diagnose per exclusionem. Tijdschrift voor Psychiatrie, 53, 813-823.
• Licht, R.W., Vestergaard, P., Kessing, L.V., Larsen, J.K., & Thomsen, P.H. (2003). Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatrica Scandinavica Supplementum, 1-22.
• Madhusoodanan, S., Brenner, R., Araujo, L., & Abaza, A. (1995). Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. Journal of Clinical Psychiatry, 6, 514-518.
• Martino, D.J., Igoa, A., Marengo, E., Scapola, M., Ais, E.D., & Strejilevich, S.A. (2008). Cognitive and motor features in elderly people with bipolar disorder. Journal of Affective Disorders, 105, 291-295.
• McFarland, B.H., Miller, M.R., & Straumfjord, A.A. (1990). Valproate use in the older manic patient. Journal of Clinical Psychiatry, 51, 479-481.
• Mordecai, D.J., Sheikh, J.I., & Glick, I.D. (1999). Divalproex for the treatment of geriatric bipolar disorder. International Journal of Geriatric Psychiatry, 14, 494-496.
• Murray, N., Hopwood, S., Balfour, D.J., Ogston, S., & Hewick, D.S. (1983). The influence of age on lithium efficacy and side-effects in out-patients. Psychological Medicine, 13, 53-60.
• Nicolato, R., Romano-Silva, M.A., Correa, H., Dos Santos, R.R., & Teixeira, A.L. (2006). Stuporous catatonia in an elderly bipolar patient: response to olanzapine. Australian and New Zealand Journal of Psychiatry, 40, 498.
• Niedermier, J.A., & Nasrallah, H.A. (1998). Clinical correlates of response to yalproate in geriatric inpatients. Annals of Clinical Psychiatry, 10, 165-168.
• Noaghiul, S., Narayan, M., & Nelson, J.C. (1998). Divalproex treatment of mania in elderly patients. American Journal of Geriatric Psychiatry, 6, 257-262.
• Perucca, E., Aldenkamp, A., Tallis, R., & Krämer, G. (2006). Role of valproate across the ages: Treatment of epilepsy in the elderly. Acta Neurologica  Scandinavica Supplementum, 184, 28-37.
• Puryear, L.J., Kunik, M.E., & Workman, R. Jr. (1995). Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses. Journal of Geriatric Psychiatry and Neurology, 8, 234-237.
• Reynolds, T., Thornicroft, G., Abas, M., Woods, B., Hoe, J., Leese, M., e.a. (2000). Camberwell Assessment of Need for the Elderly (CANE): Development, validity and reliability. British Journal of Psychiatry, 176, 444-452.
• Risinger, R.C., Risby, E.D., & Risch, S.C. (1994). Safety and efficacy of divalproex sodium in elderly bipolar patients. Journal of Clinical Psychiatry, 55, 215.
• Robillard, M., & Conn, D.K. (2002). Lamotrigine use in geriatric patients with bipolar depression. Canadian Journal of Psychiatry, 47, 767-770.
• Sajatovic, M., Gyulai, L., Calabrese, J.R., Thompson, T.R., Wilson, B.G., White, R., e.a. (2005a). Maintenance treatment outcomes in older patients with bipolar I disorder. American Journal of Geriatric Psychiatry, 13, 305-311.
• Sajatovic, M., Madhusoodanan, S., & Coconcea, N. (2005b). Managing bipolar disorder in the elderly: defining the role of the newer agents [Review]. Drugs and Aging, 22, 39-54.
• Sajatovic, M., Calabrese, J.R., & Mullen, J. (2008a). Quetiapine for the treatment of bipolar mania in older adults. Bipolar Disorders, 10, 662-671.
• Sajatovic, M., Coconcea, N., Ignacio, R.V., Blow, F.C., Hays, R.W., Cassidy, K.A., e.a. (2008b). Aripiprazole therapy in 20 older adults with bipolar disorder:  a 12-week, open-label trial. Journal of Clinical Psychiatry, 69, 41-46.
• Sajatovic, M., Gildengers, A., Al Jurdi, R.K., Gyulai, L., Cassidy, K.A., Greenberg, R.L., e.a. (2011). Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report. Bipolar Disorders, 13, 294-302.
• Samamé, C., Martino, D.J., & Strejilevich, S.A. (2013). A quantitative review of neurocognition in euthymic late-life bipolar disorder. Bipolar Disorders, 15, 633-644.
• Sanderson, D.R. (1998). Use of mood stabilizers by hospitalized geriatric patients with bipolar disorder. Psychiatric Services, 49, 1145-1147.
• Schaffer, C.B., Batra, K., Garvey, M.J., Mungas, D.M., & Schaffer, L.C. (1984). The effect of haloperidol on serum levels of lithium in adult manic patients. Biological Psychiatry, 19, 1495-1499.
• Schneeweiss, S., Setoguchi, S., Brookhart, A., Dormuth, C., & Wang, P.S. (2007). Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. Canadian Medical Association Journal, 176, 627-632.
• Schneider, A.L., & Wilcox, C.S. (1998). Divalproate augmentation in lithiumresistant rapid cycling mania in four geriatric patients. Journal of Affective Disorders, 47, 201-205.
• Schouws, S.N., Comijs, H.C., Stek, M.L., Dekker, J., Oostervink, F., Naarding, P., e.a. (2009). Cognitive impairment in early and late bipolar disorder.  American Journal of Geriatric Psychiatry, 17, 508-515.
• Schouws, S.N., Stek, M.L., Comijs, H.C., & Beekman, A.T. (2010). Risk factors for cognitive impairment in elderly bipolar patients. Journal of Affective Disorders, 125, 330-335.
• Schouws, S.N., Comijs, H.C., Stek, M.L., & Beekman, A.T. (2012). Self-reported cognitive complaints in elderly bipolar patients. American Journal of  Geriatric Psychiatry, 20, 700-706.
• Setoguchi, S., Wang, P.S., Alan Brookhart, M., Canning, C.F., Kaci, L., & Schneeweiss, S. (2008). Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications. Journal of the  American Geriatrics Society, 56, 1644-1650.
• Sharma, V., Persad, E., Mazmanian, D., & Karunaratne, K. (1993). Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium. Canadian Journal of Psychiatry, 38, 137-139.
• Shulman, R.W., Singh, A., & Shulman, K.I. (1997). Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacology Bulletin, 33, 113-118.
• Stone, K. (1989). Mania in the elderly. British Journal of Psychiatry, 155, 220-224.
• Tamashiro, J.H., Zung, S., Zanetti, M.V., De Castro, C.C., Vallada, H., Busatto, G.F., e.a. (2008). Increased rates of white matter hyperintensities in lateonset bipolar disorder. Bipolar Disorders, 10, 765-775.
• Unutzer, J., Simon, G., Pabiniak, C., Bond, K., & Katon, W. (1998). The treated prevalence of bipolar disorder in a large staff-model HMO. Psychiatric Services, 49, 1072-1078.
• Velde, C.D. van der (1970). Effectiveness of lithium carbonate in the treatment of manic-depressive illness. American Journal of Psychiatry, 123, 345-351.
• Wang, P.S., Schneeweiss, S., Avorn, J., Fischer, M.A., Mogun, H., Solomon, D.H., e.a. (2005). Risk of death in elderly users of conventional vs. atypical antipsychotic medications. New England Journal of Medicine, 353, 2335-2341.
• Wiersma, D. (2006). Needs of people with severe mental illness. Acta Psychiatrica Scandinavica, S429, 115-119.
• Young, R.C. (2005). Evidence-based pharmacological treatment of geriatric bipolar disorder. Psychiatric Clinics of North America, 28, 837-869.